MARK RICHARD J

SEC Form 4 insider trading activity

MARK RICHARD J has filed 4 SEC Form 4 filings (5 transaction rows) across 2 companies, including THC, SRE, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Sep 15, 2026.

On the most recent filing, MARK RICHARD J is listed as Director at TENET HEALTHCARE CORP. Inside the rolling window, MARK RICHARD J reported 1 open-market purchase totaling $251K in SRE and 1 open-market sale totaling $2.6M in THC. The largest disclosed transaction in the window is a sale of 10,000 THC shares on Sep 10, 2026, worth $2.6M.

Companies traded

Other insiders at THC

Insider Buying

$251K

reported purchases (SEC code P)

Insider Selling

$2.6M

reported sales (SEC code S)

Companies

2

in the rolling window

Source
THC
MARK RICHARD J
Sale$2.6MSep 15SEC ↗
SRE
MARK RICHARD J
Purchase$251KMar 11SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has MARK RICHARD J made?

MARK RICHARD J has filed 4 SEC Form 4 filings (5 transaction rows) across 2 companies, including THC, SRE since 2026.

Which companies does MARK RICHARD J trade?

MARK RICHARD J has filed SEC Form 4 disclosures for 2 companies, including THC, SRE.

When was MARK RICHARD J's most recent SEC Form 4 filing?

MARK RICHARD J's most recent SEC Form 4 filing on Tracefour is dated Sep 15, 2026.

What is MARK RICHARD J's total buy and sell value in the current window?

Inside the rolling retention window, MARK RICHARD J bought $251K and sold $2.6M based on SEC Form 4 filings.

What was MARK RICHARD J's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 10,000 THC shares on 2026-09-10, worth $2.6M, per SEC Form 4 filings.